PD-0yr (untreated Parkinson’s disease patients), PD-1yr (patients treated for one year), PD-2yr (patients treated for two years)

This prospective study of 34 biopsy- proven GCA with vision loss and treatment with GC showed a deterioration of visual acuity by 2 or more lines in 27% of the patients despite GC

GS- 09- Ramucirumab for pa- tients with advanced hepatocellular carcinoma and elevated alpha- fetoprotein following sorafenib: outcomes by liver disease aetiology from

of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial.. Prinssen

In our series, the risk for permanent neurological def- icits after surgery was significantly higher in symptom- atic patients (overall risk 23.7%) compared to their

This is mainly due to the heterogeneity of the data concerning the effect of statin therapy on bone formation markers, BMD in females and overall BMD and fracture risk, 3 as

[r]

In the 5-year follow-up data of the “RESPONSE 1” study [24], an increased risk of SM was observed in the group of patients initially treated with RUX compared with the BAT and the

[1] reporting a case series of seven patients affected by multiple sclerosis (MS), in treatment with dimethyl fumarate (DMF), that developed a self-limit- ing SARS-CoV-2 infection